XML 109 R127.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Condensed Consolidating Financial Information (Condensed Consolidating Statements of Earnings (Losses) and Comprehensive Earnings (Losses)) (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Condensed Financial Statements, Captions [Line Items]                      
Net revenues $ 6,007 $ 6,856 $ 6,619 $ 5,628 $ 6,114 $ 6,837 $ 6,305 $ 6,108 $ 25,110 $ 25,364 $ 25,576
Cost of sales                 7,085 7,373 7,531
Excise taxes on products                 5,314 5,737 6,082
Gross profit 3,084 3,497 3,319 2,811 2,922 3,255 3,141 2,936 12,711 12,254 11,963
Marketing, administration and research costs                 2,226 2,756 2,338
Asset Impairment and Exit Costs                 159 383 32
Operating (expense) income                 10,326 9,115 9,593
Interest and other debt expense, net                 1,280 665 705
Net periodic benefit (income) cost, excluding service cost                 (37) (34) 37
Earnings from equity investments                 (1,725) (890) (532)
Impairment of JUUL equity securities 4,100 4,500 0 0         8,600 0 0
Loss on Cronos-related financial instruments                 1,442 0 0
(Gain) loss on ABI/SABMiller business combination         0 0 0 33 0 33 (445)
Earnings (losses) before income taxes                 766 9,341 9,828
Provision (benefit) for income taxes                 2,064 2,374 (399)
Equity earnings (losses) of subsidiaries                 0 0 0
Net earnings (losses) (1,814) (2,602) 1,997 1,121 1,251 1,944 1,877 1,895 (1,298) 6,967 10,227
Net (earnings) losses attributable to noncontrolling interests                 5 (4) (5)
Net earnings (losses) attributable to Altria $ (1,809) $ (2,600) $ 1,996 $ 1,120 $ 1,250 $ 1,943 $ 1,876 $ 1,894 (1,293) 6,963 10,222
Other comprehensive earnings (losses), net of deferred income taxes                 (317) (242) 155
Comprehensive earnings (losses)                 (1,615) 6,725 10,382
Comprehensive (earnings) losses attributable to noncontrolling interests                 5 (4) (5)
Comprehensive earnings (losses) attributable to Altria                 (1,610) 6,721 10,377
Reportable Legal Entities [Member] | Altria Group, Inc. [Member]                      
Condensed Financial Statements, Captions [Line Items]                      
Net revenues                 0 0 0
Cost of sales                 0 0 0
Excise taxes on products                 0 0 0
Gross profit                 0 0 0
Marketing, administration and research costs                 182 219 161
Asset Impairment and Exit Costs                 1 0 0
Operating (expense) income                 (183) (219) (161)
Interest and other debt expense, net                 1,152 511 510
Net periodic benefit (income) cost, excluding service cost                 5 16 12
Earnings from equity investments                 (1,229) (890) (532)
Impairment of JUUL equity securities                 0    
Loss on Cronos-related financial instruments                 0    
(Gain) loss on ABI/SABMiller business combination                   33 (445)
Earnings (losses) before income taxes                 (111) 111 294
Provision (benefit) for income taxes                 (243) 36 (2,624)
Equity earnings (losses) of subsidiaries                 (1,425) 6,888 7,304
Net earnings (losses)                 (1,293) 6,963 10,222
Net (earnings) losses attributable to noncontrolling interests                 0 0 0
Net earnings (losses) attributable to Altria                 (1,293) 6,963 10,222
Other comprehensive earnings (losses), net of deferred income taxes                 (317) (242) 155
Comprehensive earnings (losses)                 (1,610) 6,721 10,377
Comprehensive (earnings) losses attributable to noncontrolling interests                 0 0 0
Comprehensive earnings (losses) attributable to Altria                 (1,610) 6,721 10,377
Reportable Legal Entities [Member] | PM USA [Member]                      
Condensed Financial Statements, Captions [Line Items]                      
Net revenues                 21,065 21,422 21,826
Cost of sales                 5,997 6,153 6,394
Excise taxes on products                 5,111 5,517 5,864
Gross profit                 9,957 9,752 9,568
Marketing, administration and research costs                 1,591 1,892 1,713
Asset Impairment and Exit Costs                 39 81 0
Operating (expense) income                 8,327 7,779 7,855
Interest and other debt expense, net                 (85) (61) (20)
Net periodic benefit (income) cost, excluding service cost                 (34) (41) 18
Earnings from equity investments                 0 0 0
Impairment of JUUL equity securities                 0    
Loss on Cronos-related financial instruments                 0    
(Gain) loss on ABI/SABMiller business combination                   0 0
Earnings (losses) before income taxes                 8,446 7,881 7,857
Provision (benefit) for income taxes                 2,102 1,980 3,127
Equity earnings (losses) of subsidiaries                 450 402 558
Net earnings (losses)                 6,794 6,303 5,288
Net (earnings) losses attributable to noncontrolling interests                 0 0 0
Net earnings (losses) attributable to Altria                 6,794 6,303 5,288
Other comprehensive earnings (losses), net of deferred income taxes                 2 104 3
Comprehensive earnings (losses)                 6,796 6,407 5,291
Comprehensive (earnings) losses attributable to noncontrolling interests                 0 0 0
Comprehensive earnings (losses) attributable to Altria                 6,796 6,407 5,291
Reportable Legal Entities [Member] | Non-Guarantor Subsidiaries [Member]                      
Condensed Financial Statements, Captions [Line Items]                      
Net revenues                 4,081 3,980 3,787
Cost of sales                 1,124 1,258 1,174
Excise taxes on products                 203 220 218
Gross profit                 2,754 2,502 2,395
Marketing, administration and research costs                 453 645 464
Asset Impairment and Exit Costs                 119 302 32
Operating (expense) income                 2,182 1,555 1,899
Interest and other debt expense, net                 213 215 215
Net periodic benefit (income) cost, excluding service cost                 (8) (9) 7
Earnings from equity investments                 (496) 0 0
Impairment of JUUL equity securities                 8,600    
Loss on Cronos-related financial instruments                 1,442    
(Gain) loss on ABI/SABMiller business combination                   0 0
Earnings (losses) before income taxes                 (7,569) 1,349 1,677
Provision (benefit) for income taxes                 205 358 (902)
Equity earnings (losses) of subsidiaries                 0 0 0
Net earnings (losses)                 (7,774) 991 2,579
Net (earnings) losses attributable to noncontrolling interests                 5 (4) (5)
Net earnings (losses) attributable to Altria                 (7,769) 987 2,574
Other comprehensive earnings (losses), net of deferred income taxes                 7 (54) 214
Comprehensive earnings (losses)                 (7,767) 937 2,793
Comprehensive (earnings) losses attributable to noncontrolling interests                 5 (4) (5)
Comprehensive earnings (losses) attributable to Altria                 (7,762) 933 2,788
Total Consolidating Adjustments [Member]                      
Condensed Financial Statements, Captions [Line Items]                      
Net revenues                 (36) (38) (37)
Cost of sales                 (36) (38) (37)
Excise taxes on products                 0 0 0
Gross profit                 0 0 0
Marketing, administration and research costs                 0 0 0
Asset Impairment and Exit Costs                 0 0 0
Operating (expense) income                 0 0 0
Interest and other debt expense, net                 0 0 0
Net periodic benefit (income) cost, excluding service cost                 0 0 0
Earnings from equity investments                 0 0 0
Impairment of JUUL equity securities                 0    
Loss on Cronos-related financial instruments                 0    
(Gain) loss on ABI/SABMiller business combination                   0 0
Earnings (losses) before income taxes                 0 0 0
Provision (benefit) for income taxes                 0 0 0
Equity earnings (losses) of subsidiaries                 975 (7,290) (7,862)
Net earnings (losses)                 975 (7,290) (7,862)
Net (earnings) losses attributable to noncontrolling interests                 0 0 0
Net earnings (losses) attributable to Altria                 975 (7,290) (7,862)
Other comprehensive earnings (losses), net of deferred income taxes                 (9) (50) (217)
Comprehensive earnings (losses)                 966 (7,340) (8,079)
Comprehensive (earnings) losses attributable to noncontrolling interests                 0 0 0
Comprehensive earnings (losses) attributable to Altria                 $ 966 $ (7,340) $ (8,079)